Thursday, May 13, 2021 |
Baltimore
70°
Mostly Cloudy
FOLLOW US:

Johnson & Johnson COVID Vaccine Maker Emergent BioSolutions Asked To Stop Making Doses While FDA Investigation Underway

April 20, 2021
Emergent BioSolutions, the Baltimore, Maryland-based company manufacturing the Johnson & Johnson coronavirus vaccines, was asked to stop manufacturing COVID-19 related products, while the Food & Drug Administration continues its investigation into quality control issues at the plant that ruined 15 million potential doses of the vaccine. The FDA initiated an inspection of the company’s Bayview facility on April 12. At the request of the FDA, Emergent BioSolutions agreed on April 16 not to make any new COVID-19 materials at this facility and to quarantine existing materials already manufactured there pending results of the inspection.
Article Source: WJZ

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.